The Gori Law Firm

Call today and get your FREE Case Review!

More Than $4 Billion Recovered For Our Clients

Injuries Caused By Zofran

GlaxoSmithKline’s Zofran And Birth Defects: Lawsuits On Behalf Of Victims

Zofran is one of the most widely prescribed drugs for the treatment of nausea and vomiting. The drug is approved by the Food and Drug Administration specifically for treating nausea related to chemotherapy, radiation treatment and surgery.

For obvious reasons, that means that few pregnant women are prescribed Zofran for its FDA-approved uses. Unfortunately, GlaxoSmithKline, the maker of Zofran, marketed the drug for off-label uses, including for the treatment of morning sickness. Studies have now connected Zofran with an increased risk of birth defects, including potentially fatal heart defects.

Holding Drugmakers Accountable

At The Gori Law Firm, we know how to hold drug manufacturers accountable for the harm their products do. When you are injured by a drug like Zofran, you are facing off against a giant corporation with a team of lawyers dedicated to avoiding responsibility. Without an experienced team on your side, your chances of recovering proper compensation are not good.

GlaxoSmithKline paid billions of dollars in fines for its illegal marketing of Zofran. It marketed the drug to pregnant women despite an absence of testing to prove that it was safe. As it turned out, the drug was not safe. Zofran has been tied to an increased risk of major congenital birth defects, including heart defects that can be fatal.

Handling Zofran Claims Nationwide

Our firm has obtained verdicts and settlements all over the country in cases involving dangerous products. We understand the pain and heartbreak of losing a loved one to a defective drug or unsafe product. That understanding fuels our commitment to providing compassionate, professional legal assistance to victims of dangerous drugs like Zofran.

To learn more about how we can help you get justice, contact us online or call 618-307-4085 to schedule a free initial consultation.